The somatic super syndrome
The somatic super syndrome is a constellation of five interconnected health conditions that commonly occur together in autistic and ADHD people, particularly those assigned female at birth (AFAB). Bendy joints. A racing heart on standing. A body that overreacts to foods, smells and products. A gut that will not settle.
The five conditions are hypermobility EDS (hEDS) and other Ehlers-Danlos syndromes (EDS), postural tachycardia syndrome (PoTS), mast cell activation syndrome (MCAS), gastrointestinal issues, particularly irritable bowel syndrome (IBS), and autoimmune.
Am I hypermobile?
Try our free anonymous hypermobility mini‑screen. Real-time scoring - no email sign up necessary.
Hypermobility mini‑screen
Nine movements, one point each. Tick the ones you can do, then read what your total means for your age. They are reproduced as published from the Beighton score, a clinically validated measure of generalised joint hypermobility.
Beighton, P., Solomon, L., & Soskolne, C. L. (1973). Articular mobility in an African population. Annals of the Rheumatic Diseases, 32(5), 413–418. https://doi.org/10.1136/ard.32.5.413
Your left little finger bends backwards beyond 90 degrees.
Your right little finger bends backwards beyond 90 degrees.
Your left thumb touches the inside of your forearm.
Your right thumb touches the inside of your forearm.
Your left elbow bends backwards beyond 10 degrees.
Your right elbow bends backwards beyond 10 degrees.
Your left knee bends backwards beyond 10 degrees.
Your right knee bends backwards beyond 10 degrees.
With your knees straight, you can bend forwards and place both palms flat on the floor.
Your score
What your score means
You are likely to be hypermobile if you scored:
6 or more out of 9 before puberty.
5 or more out of 9 from puberty to 50.
4 or more out of 9 over 50.
Cut-offs as published by the Ehlers-Danlos Society. A score at or above the cut-off for your age is not a diagnosis, and a score below it does not rule hypermobility out.
Signposting
SEDSConnective
SEDS Connective is a charity dedicated to supporting neurodivergent people with hypermobility EDS (hEDS). SEDS was founded by Jane Green MBE, whose vision is a world where neurodivergent people with hypermobility are understood, supported and empowered to thrive.
Signposting
The Ehlers-Danlos Society
The Ehlers-Danlos Society is the international charity for people living with the Ehlers-Danlos syndromes and hypermobility spectrum disorders. They publish the criteria used in this mini‑screen and run a worldwide directory of support groups.
The vagus nerve
The vagus nerve is the body's superhighway that carries signals from the brain to major organs including the heart, lungs, stomach, liver, and the digestive system1-4. It plays a key role in activating the body's parasympathetic system or rest and digest response, calming the body and mind1-4.
The sympathetic nervous system activates the body's fight or flight alarm, which is triggered in response to stress, threat, or trauma. It is thought to be overactive in autistic and ADHD people, leading to heightened anxiety and a wide range of somatic symptoms, particularly among females5,6.
Chronic stress sensitises the nervous system and increases pain. Neurodivergent women report incredibly high rates of central sensitivity syndromes (CSS), particularly migraines, IBS, temporomandibular joint dysfunction (TMJ), myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS), fibromyalgia, myofascial pain syndrome, chronic pelvic pain, and very painful periods (dysmenorrhoea)7-10.
Chronic stress increases inflammation. Inflammation in the body can trigger mast cell release and allergy-like reactions in MCAS. Neuroinflammation, that is inflammation of the brain, can lead to neurotoxicity and neurodegeneration24-28.
Systemic inflammation is the common thread that connects the somatic super syndrome29.
The trigeminal nerve
Neurodivergent women commonly struggle with a constellation of problems connected to the trigeminal nerve and joint instability11,12:
- Teeth grinding (bruxism)
- TMJ
- Sinus congestion
- Tension headaches
- Migraines
- Tinnitus
- Vertigo
TMJ and migraine affect three times as many females13. Joint instability is a symptom of EDS14,15.
The trigeminal nerve is responsible for sending sensory processing signals to the brain from your face and head and controls movement in the face and jaw. It branches across your forehead, cheeks, and jawline16,17.
TMJ is impaired movement and pain in the temporomandibular joint18,19. Constant clenching can irritate the trigeminal nerve and trigger TMJ. Teeth grinding (bruxism) is most often caused by stress or anxiety.
Sinusitis can also trigger TMJ by causing pressure and nerve irritation. TMJ can cause symptoms that mimic sinusitis or ear infection making them tricky to tell apart (talk to your doctor)20,21.
The masseter muscle (jaw muscle) is the most powerful muscle in the body relative to its size. Over time the masseter muscle becomes larger and stronger, creating a pain loop that is hard to break22,23.
Handpicked for bendy bodies and curious brains
Questions? Ask Uma.
Connective tissue is the material that holds you together. It is in your skin, your ligaments and tendons, the walls of your blood vessels, your gut, and the covering around every organ. Collagen is its main structural protein.
That list is why a difference in connective tissue does not stay in your joints. If the same material is in the blood vessel walls and the gut wall, a difference in it can show up in blood pressure and digestion as well as in bendy fingers.45
Joints that move further than the usual range. On its own that is a description, not a condition, and plenty of people have it without any trouble at all.
What does differ, measurably, is position sense. A 2025 study found hypermobile people had poorer joint position sense at the elbow and knee, while grip strength and functional stability were no different from anyone else.42
Same thing, different words. Double jointed is the playground term and it is inaccurate, because nobody has two sets of joints. The joints simply move further.
The useful question is not whether you are bendy but whether it causes you problems, and that is a separate question with a separate answer below.
When it comes with symptoms: pain, joints that give way or dislocate, fatigue, and the other body systems joining in.
A survey of people with hypermobility in a localised or historical pattern, rather than the classic widespread one, found they reported significantly more symptoms and co-occurring conditions than expected.33 Being bendy in only a few places does not mean being mildly affected.
Hypermobile Ehlers-Danlos syndrome, hEDS, is a heritable connective tissue condition diagnosed on clinical criteria rather than a blood test. It is described as likely the most common heritable connective tissue disorder, and as underdiagnosed, partly because it lacks the obvious skin features of the other types.14
There is still no gene test for it. When genetic testing was used in people who met the clinical criteria, 26.4 per cent turned out to have an additional or alternative diagnosis, which tells you both that the criteria catch a mixed group and that testing has a role in sorting it out.32
Hypermobility spectrum disorder, HSD, is symptomatic hypermobility that does not meet the full hEDS criteria. It is not a lesser problem, it is a different label.
A global survey put numbers on that. People with hEDS reported an average of 24 co-occurring conditions and a diagnostic delay of 22.1 years. For HSD it was 17 conditions and 17.5 years.34 Both groups wait most of their adult lives.
The Beighton score is the nine point check for how far a set of joints move. It is quick, it is widely used, and it has real limits that are worth knowing before you take a score to heart.
A review of the evidence found agreement between examiners is moderate at best, and rated the reliability evidence as limited to conflicting. The familiar cut-off of four or more has no evidence-based derivation behind it. Two thirds of the joints it tests are in the upper limb, so it does not capture how systemic your hypermobility is, and a low score cannot rule generalised hypermobility out.30
A 2026 systematic review with meta-analysis set out to fix exactly that by deriving cut-offs from data rather than convention.31
So: a useful starting point, not a verdict.
Because flexibility and stability are not the same thing. A joint that travels further has further to travel before anything stops it, and the muscles around it work harder to do the job the ligaments are doing less of.
Hypermobility is well represented in chronic pain populations.15 There is also emerging work implicating the position sensors in muscle themselves in the development of widespread soreness, rather than pain nerves alone.41 That is early laboratory science, not an explanation of your pain.
Proprioception is your sense of where your body is without looking at it, and it is measurably less accurate in hypermobile people at the elbow and knee.42
If the information about where your arm is arrives slightly blurred, you find door frames with it. That is a sensory difference, not clumsiness in the character sense.
Standing up is a challenge your body has to answer. Blood drops towards your legs, and your nervous system has to tighten the blood vessels and adjust your heart rate to keep blood going to your brain. If the vessel tightening is weaker than it should be, the heart rate has to do more of the work, so it climbs.
A sustained rise of more than 30 beats per minute on standing, with symptoms, is the pattern that defines postural tachycardia syndrome.37
Postural tachycardia syndrome, PoTS, is that sustained rise in heart rate on standing together with symptoms such as dizziness, breathlessness, fatigue and brain fog, in the absence of a drop in blood pressure that would explain it.37
It is a recognised condition with a substantial disability burden, and it needs proper testing and specialist input rather than reassurance.37
Dysautonomia is the umbrella term for the automatic nervous system not regulating properly. PoTS is one form of it. That system handles heart rate, blood pressure, temperature, digestion, sweating and bladder, which is why dysautonomia rarely shows up as one tidy symptom.48
It occurs alongside a long list of other conditions rather than only on its own.48
Yes, and this is where a lot of women lose years.
A racing heart, breathlessness, shakiness and a sense of dread are what an anxiety attack feels like and also what an autonomic response feels like, because they involve the same machinery. The difference is what sets it off: standing up, heat, a hot shower, a large meal.
There is published work on the connective tissue and autonomic route into psychiatric symptoms specifically, arguing that the body's signalling is part of the picture rather than a misreading of it.45
Anxiety can be real and present at the same time. The point is that it should not be the only thing anyone looks at.
Mast cells are immune cells that sit in the tissues that meet the outside world: skin, airway, gut. When triggered they release histamine and other chemical messengers, which is what produces flushing, itching, swelling and the rest of an allergic-type response.
They also talk to the brain. There is a research literature on mast cells and behaviour, including their role in conditions that are usually thought of as neurological rather than immune.24
Mast cell activation syndrome, MCAS, is mast cells releasing their contents when they should not, producing symptoms across several body systems at once without a classical allergy to explain it.
A case series described the neuropsychiatric side of it specifically, which is the part most often missed when someone presents with brain fog and anxiety rather than hives.47
MCAS is a contested area of medicine with criteria that are still argued over. Uma will not pretend that argument is finished.
Because oestrogen acts on mast cells. That mechanism is established in cell and animal work: estradiol activates mast cells through a rapid route involving calcium, and mast cells from animals lacking the relevant oestrogen receptor do not respond to it.49
The human side is observational. A substantial proportion of women with asthma report symptoms worsening around menstruation.49
So the mechanism is laboratory evidence and the monthly pattern is an observed association. Uma keeps those two apart.
Three reasons that stack. The gut wall is connective tissue. The gut is run by the automatic nervous system. And mast cells live in the gut lining.
There is a clinical review written specifically for gastroenterologists on hEDS and the gut, which is a fair indication that the association is taken seriously in that specialty rather than being an internet theory.35
A scoping review of brain fog in chronic pain describes it as a fluctuating state affecting memory, attention and daily functioning, and says plainly that it remains poorly defined and poorly understood.43
In PoTS there is a mechanism worth knowing: if blood flow to the brain is not maintained properly when you are upright, thinking is harder when you are upright.38 That is a plausible route, not a settled cause.
Fog is a real, describable phenomenon that has not been properly studied. Those are two different statements and both are true.
The overlap is documented. A survey of 733 people with hEDS or HSD found high overlap with fibromyalgia and with 40 self-reported symptoms and co-occurring conditions.44 A study of hEDS using formal autonomic testing found cerebrovascular, autonomic and small fibre findings in the same group.38
What is not established is that these three form a single named syndrome with one cause. The associations are real and repeatedly observed. The underlying mechanism is still being worked out, and the diagnostic boundaries are still argued over.
Uma describes them as often reported together rather than as a triad, because that is what the evidence supports.
The association is reported in both directions. A retrospective study of children with hypermobility spectrum disorders or hEDS found ADHD diagnosed at more than three times the general population rate.39 A review of autism and the Ehlers-Danlos syndromes sets out shared genetic and nervous system features and raised rates of one alongside the other.40
A study using formal autonomic testing in autistic people found 71 per cent had an autonomic condition, most commonly PoTS, and of those, 80 per cent also had hEDS.36 That was a clinic sample rather than the general autistic population, which matters for how far the number travels.
There is a published model for exactly this. It links emotional dysregulation in neurodivergent people to the effect hypermobility has on proprioception, the sense of where your body is.46 In the data behind it, the link between imprecise proprioception and emotional dysregulation appeared only in people who were also hypermobile.46
It is a proposed model built on a cross-sectional study, so treat it as the best current explanation rather than a proven chain.
Because the standard panel is not testing for any of this.
hEDS has no blood test. It is diagnosed on clinical criteria, and genetic testing is used to rule other things out rather than to confirm it.14,32 PoTS is diagnosed by measuring heart rate and blood pressure on standing, which a routine appointment does not do.37 The autonomic findings in hEDS were picked up using formal autonomic testing, not a blood count.38
A clear result on a test that was never looking for your condition is not evidence that nothing is wrong. The average diagnostic delay of 22.1 years in hEDS is built out of exactly those appointments.34
1. Berthoud, H. R., & Neuhuber, W. L. (2000). Functional and chemical anatomy of the afferent vagal system. Autonomic Neuroscience, 85(1–3), 1–17. https://doi.org/10.1016/S1566-0702(00)00215-0
2. Thayer, J. F., & Lane, R. D. (2000). A model of neurovisceral integration. Biological Psychology, 74(2), 173–184. https://pubmed.ncbi.nlm.nih.gov/11163422/
3. Bonaz, B., Sinniger, V., & Pellissier, S. (2019). Vagus nerve stimulation at the interface of brain–gut interactions. Cold Spring Harbor Perspectives in Medicine, 9(8), Article a034199. https://pmc.ncbi.nlm.nih.gov/articles/PMC6671930/
4. Carabotti, M., Scirocco, A., Maselli, M. A., & Severi, C. (2015). The gut–brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenterology, 28(2), 203–209. https://pmc.ncbi.nlm.nih.gov/articles/PMC4367209/
5. Porges, S. W. (2007). The polyvagal perspective. Biological Psychology, 74(2), 116–143. https://doi.org/10.1016/j.biopsycho.2006.06.009
6. Thayer, J. F., & Sternberg, E. (2010). Neural aspects of immunomodulation: Focus on the vagus nerve. Physiological Reviews, 90(2), 705–740. https://doi.org/10.1152/physrev.00018.2009
7. Affatato, O., Miguet, M., Schiöth, H. B., & Mwinyi, J. (2021). Major sex differences in migraine prevalence among occupational categories: A cross-sectional study using UK Biobank. The Journal of Headache and Pain, 22, 145. https://pmc.ncbi.nlm.nih.gov/articles/PMC8903549/
8. Bartels, E. M., Dreyer, L., Jacobsen, S., Jespersen, A., Bliddal, H., & Danneskiold-Samsøe, B. (2009). Fibromyalgia, diagnosis and prevalence. Are gender differences explainable? Ugeskrift for Laeger, 171(49), 3588–3592. https://pubmed.ncbi.nlm.nih.gov/19954696/
9. Wolfe, F., Walitt, B., Perrot, S., Rasker, J. J., & Häuser, W. (2018). Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias. PLOS ONE, 13(9), e0203755. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0203755
10. Samms, G. L., & Ponting, C. P. (2025). Unequal access to diagnosis of myalgic encephalomyelitis in England. BMC Public Health, 25, 1417. https://pmc.ncbi.nlm.nih.gov/articles/PMC12012970/
11. Ismail, F., & Nielsen, R. (2020). The trigeminal nerve and migraine pathophysiology. Current Opinion in Neurology, 33(3), 312–317.
12. Ashina, S., Bentley, J. N., Goadsby, P. J., & Messlinger, K. (2018). Migraine and the trigeminovascular system. Cephalalgia, 38(13), 1731–1742.
13. Manfredini, D., Guarda-Nardini, L., Winocur, E., Piccotti, F., Terrenin, L., & Lobbezoo, F. (2013). Prevalence of temporomandibular disorders in females: A systematic review. Journal of Oral Rehabilitation, 40(5), 321–329.
14. Castori, M. (2012). Ehlers-Danlos syndrome, hypermobility type: An underdiagnosed hereditary connective tissue disorder. Clinical and Experimental Rheumatology, 30(4), 10–16.
15. Lipscombe, J., Evans, A., & Grahame, R. (2016). Joint hypermobility and Ehlers-Danlos syndrome in chronic pain populations. Clinical Rheumatology, 35(8), 1965–1971.
16. Ismail, F., & Nielsen, R. (2020). The trigeminal nerve and migraine pathophysiology. Current Opinion in Neurology, 33(3), 312–317.
17. Ashina, S., Bentley, J. N., Goadsby, P. J., & Messlinger, K. (2018). Migraine and the trigeminovascular system. Cephalalgia, 38(13), 1731–1742.
18. Okeson, J. P. (2013). Management of temporomandibular disorders and occlusion (7th ed.). Elsevier.
19. Nixdorf, D. R., Velly, A. M., & Alonso, A. A. (2014). Temporomandibular disorders and chronic pain: Clinical considerations. Dental Clinics of North America, 58(4), 739–755.
20. Okeson, J. P. (2013). Management of temporomandibular disorders and occlusion (7th ed.). Elsevier.
21. Nixdorf, D. R., Velly, A. M., & Alonso, A. A. (2014). Temporomandibular disorders and chronic pain: Clinical considerations. Dental Clinics of North America, 58(4), 739–755.
22. Manfredini, D., Guarda-Nardini, L., Winocur, E., Piccotti, F., Terrenin, L., & Lobbezoo, F. (2013). Prevalence of temporomandibular disorders in females: A systematic review. Journal of Oral Rehabilitation, 40(5), 321–329.
23. Okeson, J. P. (2013). Management of temporomandibular disorders and occlusion (7th ed.). Elsevier.
24. Theoharides, T. C., Stewart, J. M., Hatziagelaki, E., & Kolaitis, G. (2015). Mast cells, brain and behavior: The role of mast cells in neuropsychiatric disorders. Frontiers in Neuroscience, 9, Article 130. https://doi.org/10.3389/fnins.2015.00130
25. Yuan, H., & Silberstein, S. D. (2016). Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part I. Headache, 56(1), 71-78. https://doi.org/10.1111/head.12647
26. Pavlov, V. A., & Tracey, K. J. (2012). The vagus nerve and the inflammatory reflex, linking immunity and metabolism. Trends in Molecular Medicine, 18(9), 500–506. https://doi.org/10.1016/j.molmed.2012.07.002
27. Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000). Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature, 405(6785), 458–462. https://doi.org/10.1038/35013070
28. Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., & Tracey, K. J. (2003). Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature, 421(6921), 384–388. https://doi.org/10.1038/nature01339
29. Eccles, J. (2026, June 18). The overlooked physical side of neurodivergence [Audio podcast episode]. In The Hidden 20%. https://open.spotify.com/episode/1eEiUeozzLSvhH1Vas79yh
30. Malek, S., Reinhold, E. J., & Pearce, G. S. (2021). The Beighton Score as a measure of generalised joint hypermobility. Rheumatology International, 41(10), 1707–1716. https://doi.org/10.1007/s00296-021-04832-4
31. Tofts, L., Pacey, V., Williams, C. M., Welch, J. J., Shannon, B., & Chan, C. (2026). Generalized joint hypermobility in adults: A systematic review with meta-analysis to identify data-driven cut-offs using the Beighton score. Arthritis Care & Research, 78(8), 987–997. https://doi.org/10.1002/acr.70017
32. Forghani, I., See, J., & McGonigle, W. C. (2025). Hypermobile Ehlers-Danlos syndrome: Diagnostic challenges and the role of genetic testing. Genes, 16(5), 530. https://doi.org/10.3390/genes16050530
33. Fairweather, D., Bruno, K. A., Darakjian, A. A., Wilson, F. C., Fliess, J. J., Murphy, E. F., Kocsis, S. C., Strandes, M. W., Weigel, G. J., Puls, A. M., Hartmoyer, C. J., Hamilton, C., Whelan, E. R., Gehin, J. M., Menton, S. M., Sledge, H., Hodge, D. O., Gajarawala, S., Munipalli, B., Shufelt, C. L., Atwal, P. S., & Knight, D. R. T. (2025). Localized and historical hypermobile spectrum disorders share self-reported symptoms and comorbidities with hEDS and HSD. Frontiers in Medicine, 12, Article 1594796. https://doi.org/10.3389/fmed.2025.1594796
34. Daylor, V., Griggs, M., Weintraub, A., Byrd, R., Petrucci, T., Huff, M., Byerly, K., Fenner, R., Severance, S., Griggs, C., Sharma, A., Atwal, P., Kautz, S. A., Shapiro, S., Youkhana, K., Lavallee, M., Wilkerson, A., Nichols, M., Snyder, A., Eichinger, J. K., Patel, S., Maitland, A., Gensemer, C., & Norris, R. A. (2025). Defining the chronic complexities of hEDS and HSD: A global survey of diagnostic challenges, life-long comorbidities, and unmet needs. Journal of Clinical Medicine, 14(16), 5636. https://doi.org/10.3390/jcm14165636
35. Thwaites, P. A., Gibson, P. R., & Burgell, R. E. (2022). Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know. Journal of Gastroenterology and Hepatology, 37(9), 1693–1709. https://doi.org/10.1111/jgh.15927
36. Owens, A. P., Mathias, C. J., & Iodice, V. (2021). Autonomic dysfunction in autism spectrum disorder. Frontiers in Integrative Neuroscience, 15, Article 787037. https://doi.org/10.3389/fnint.2021.787037
37. Kavi, L. (2021). Postural tachycardia syndrome and long COVID: An update. British Journal of General Practice, 72(714), 8–9. https://doi.org/10.3399/bjgp22X718037
38. Novak, P., Systrom, D. M., Marciano, S. P., Witte, A., Warren, A., Felsenstein, D., Giannetti, M. P., Hamilton, M. J., Nicoloro-SantaBarbara, J., Castells, M., Farhad, K., Pilgrim, D. M., Mullally, W. J., Fishman, M. C., Milunsky, J. M., Milunsky, A., & Krier, J. (2025). Hypermobile Ehlers-Danlos syndrome: Cerebrovascular, autonomic and neuropathic features. American Journal of Medicine Open, 14, 100111. https://doi.org/10.1016/j.ajmo.2025.100111
39. Kindgren, E., Quiñones Perez, A., & Knez, R. (2021). Prevalence of ADHD and autism spectrum disorder in children with hypermobility spectrum disorders or hypermobile Ehlers-Danlos syndrome: A retrospective study. Neuropsychiatric Disease and Treatment, 17, 379–388. https://doi.org/10.2147/NDT.S290494
40. Casanova, E. L., Baeza-Velasco, C., Buchanan, C. B., & Casanova, M. F. (2020). The relationship between autism and Ehlers-Danlos syndromes/hypermobility spectrum disorders. Journal of Personalized Medicine, 10(4), 260. https://doi.org/10.3390/jpm10040260
41. Lee, C.-H., Lin, J.-H., Lin, S.-H., Chang, C.-T., Wu, Y.-W., Bewick, G., Banks, R. W., Gründer, S., Hochgeschwender, U., & Chen, C.-C. (2025). A role for proprioceptors in sngception. Science Advances, 11(5), eabc5219. https://doi.org/10.1126/sciadv.abc5219
42. Akaras, E., Deniz, G., Eymir, M., & Sönmez, M. (2025). The effects of joint hypermobility on strength, proprioception, and functional performance. Scientific Reports, 15(1), Article 24199. https://doi.org/10.1038/s41598-025-24199-x
43. Dass, R., Kalia, M., Harris, J., & Packham, T. (2023). Understanding the experience and impacts of brain fog in chronic pain: A scoping review. Canadian Journal of Pain, 7(1), 2217865. https://doi.org/10.1080/24740527.2023.2217865
44. Fairweather, D., Bruno, K. A., Darakjian, A. A., Bruce, B. K., Gehin, J. M., Kotha, A., Jain, A., Peng, Z., Hodge, D. O., Rozen, T. D., Munipalli, B., Rivera, F. A., Malavet, P. A., & Knight, D. R. T. (2023). High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities. Frontiers in Medicine, 10, Article 1096180. https://doi.org/10.3389/fmed.2023.1096180
45. Sharp, H. E. C., Critchley, H. D., & Eccles, J. A. (2021). Connecting brain and body: Transdiagnostic relevance of connective tissue variants to neuropsychiatric symptom expression. World Journal of Psychiatry, 11(10), 805–820. https://doi.org/10.5498/wjp.v11.i10.805
46. Eccles, J. A., Quadt, L., Garfinkel, S. N., & Critchley, H. D. (2024). A model linking emotional dysregulation in neurodivergent people to the proprioceptive impact of joint hypermobility. Philosophical Transactions of the Royal Society B: Biological Sciences, 379(1908), Article 20230247. https://doi.org/10.1098/rstb.2023.0247
47. Weinstock, L. B., Nelson, R. M., & Blitshteyn, S. (2023). Neuropsychiatric manifestations of mast cell activation syndrome and response to mast-cell-directed treatment: A case series. Journal of Personalized Medicine, 13(11), 1562. https://doi.org/10.3390/jpm13111562
48. Blitshteyn, S. (2025). Dysautonomia: A common comorbidity of systemic disease. Immunologic Research, 73(1), Article 9661. https://doi.org/10.1007/s12026-025-09661-2
49. Zierau, O., Zenclussen, A. C., & Jensen, F. (2012). Role of female sex hormones, estradiol and progesterone, in mast cell behavior. Frontiers in Immunology, 3, 169. https://doi.org/10.3389/fimmu.2012.00169